Literature DB >> 11975683

Use of herbs in women diagnosed with ovarian cancer.

C Bethan Powell1, S L Dibble, J E Dall'Era, I Cohen.   

Abstract

Of 113 consecutive ovarian cancer patients identified in a gynecologic clinic in a major academic medical center in San Francisco, 41 patients were successfully contacted, were eligible, and participated in a telephone survey. We contacted women identified consecutively in the clinic database as having ovarian cancer and sent a letter introducing our research team and asking for help. Members of the research team then contacted the women to conduct the telephone interviews. Fifty-one percent (95% CI 35-67) of the women had taken herbs sometime since they were diagnosed with ovarian cancer. Most herb uses occurred concurrently with chemotherapy. Only 12% (95% CI 4-26) used an herbalist or other health practitioner for guidance in herb use. Only one woman took herbs instead of chemotherapy. A large number of women attending our practice in the San Francisco Bay area use herbs as complementary medicine during their cancer treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11975683     DOI: 10.1046/j.1525-1438.2002.01098.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

1.  Complementary and alternative medicine: use and disclosure in radiation oncology community practice.

Authors:  Sarah M Rausch; Frankie Winegardner; Kelly M Kruk; Vaishali Phatak; Dietlind L Wahner-Roedler; Brent Bauer; Ann Vincent
Journal:  Support Care Cancer       Date:  2010-03-25       Impact factor: 3.603

2.  Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Altern Complement Med       Date:  2012-03       Impact factor: 2.579

Review 3.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Authors:  Esther L Davis; Byeongsang Oh; Phyllis N Butow; Barbara A Mullan; Stephen Clarke
Journal:  Oncologist       Date:  2012-08-29

4.  Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer.

Authors:  Bin Pan; Tao Cheng; Ke-Jun Nan; Gen-Quan Qiu; Xi-Cai Sun
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

5.  Soliciting an herbal medicine and supplement use history at hospice admission.

Authors:  Holly M Holmes; Karen Kaiser; Steve Jackson; Mary Lynn McPherson
Journal:  J Palliat Med       Date:  2010-06       Impact factor: 2.947

6.  Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport.

Authors:  Shuzhong Zhang; Xinning Yang; Marilyn E Morris
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.

Authors:  Shuzhong Zhang; Marilyn E Morris
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

9.  The Public Health Impact of Herbs and Nutritional Supplements.

Authors:  Barrie R Cassileth; Marjet Heitzer; Kathleen Wesa
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

10.  Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation.

Authors:  Marie H Hanigan; Brian L Dela Cruz; David M Thompson; Kevin C Farmer; Patrick J Medina
Journal:  J Oncol Pharm Pract       Date:  2008-09       Impact factor: 1.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.